Skip to content

Cipla Limited Price, Chart & Factor Exposure

Free Data & Analytics Access

Next earnings: Thu, Jan 21, 2027, before the market opens · estimates and history

Cipla Limited · E.CIPLA.NSE · India
Use symbol E.CIPLA.NSE in our API & Excel add-in to retrieve this data ↓
1,387.00
(+0.01%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 50%
Trend 0%
Bubble Risk LOW
Realised Volatility (20D) 15.05%

Cipla Limited Forecast

Cipla Limited short-term momentum is positive (up over 3 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is neutral (4 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term NEUTRAL signal. Based on 20-day realised volatility of 15.0% a year, a typical one-standard-deviation range is 1,358–1,416 over a week, 1,327–1,447 over a month and 1,178–1,596 over a year. (Signals as of 5 Nov 2026.)

Cipla Limited Price Chart

MacroFinance.ai
Market/MacroIndicatorNowChangeRange
Quantitative
Cipla Limited
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Cipla Limited
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Cipla Limited
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Cipla Limited
P/E
38.72x
Stretched vs own history
QoQ +12.7%
YoY +72.5%
now 38.722322.09 low39.5 high
ⓘP/E As of 22 Nov 2026.See Cipla Limited returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Cipla Limited
P/S
4.01x
Mid-range vs own history
QoQ −2.3%
YoY −7.3%
now 4.01373.44 low4.38 high
ⓘP/S As of 22 Nov 2026.See Cipla Limited returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Cipla Limited
P/B
3.17x
Cheap vs own history
QoQ −5.5%
YoY −14.6%
now 3.16932.8 low3.76 high
ⓘP/B As of 22 Nov 2026.See Cipla Limited returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Cipla Limited
EV/EBITDA
20.03x
Stretched vs own history
QoQ +21.3%
YoY +37.3%
now 20.034113.42 low20.47 high
ⓘEV/EBITDA As of 22 Nov 2026.See Cipla Limited returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Cipla Limited
EV/Sales
3.74x
Mid-range vs own history
QoQ −1.9%
YoY −7.5%
now 3.74393.1 low4.11 high
ⓘEV/Sales As of 22 Nov 2026.See Cipla Limited returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Cipla Limited
Earnings Yield
2.6%
Weak vs own history
QoQ −11.3%
YoY −42.0%
now 2.58252.53 low4.53 high
ⓘEarnings Yield As of 22 Nov 2026.See Cipla Limited returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Cipla Limited
Market Cap
$1.12T
Mid-range vs own history
QoQ −3.1%
YoY −8.2%
now 1121795.891964,071 low1,237,468 high
ⓘMarket Cap As of 22 Nov 2026.See Cipla Limited returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Cipla Limited
Net Debt
-$75.4B
Mid-range vs own history
QoQ −19.9%
YoY −4.2%
now -75388.4-94,144 low-75,388 high
ⓘNet Debt As of 22 Nov 2026.See Cipla Limited returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Cipla Limited
Net Debt / EBITDA
-1.44x
Low vs own history
QoQ −0.6%
YoY +43.7%
now -1.4434-1.45 low-1 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Cipla Limited returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Cipla Limited
Current Ratio
3.59x
Mid-range vs own history
QoQ +4.3%
YoY −9.2%
now 3.59213.44 low3.96 high
ⓘCurrent Ratio As of 22 Nov 2026.See Cipla Limited returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Cipla Limited
Quick Ratio
2.62x
Mid-range vs own history
QoQ +4.7%
YoY −12.0%
now 2.62062.5 low2.98 high
ⓘQuick Ratio As of 22 Nov 2026.See Cipla Limited returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Cipla Limited
Interest Coverage
64.22x
Mid-range vs own history
QoQ −19.7%
YoY −46.4%
now 64.217564.22 low119.82 high
ⓘInterest Coverage As of 22 Nov 2026.See Cipla Limited returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Cipla Limited
Debt / Equity
0.02x
Mid-range vs own history
QoQ +11.1%
YoY +39.5%
now 0.01980.01 low0.02 high
ⓘDebt / Equity As of 22 Nov 2026.See Cipla Limited returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Cipla Limited
Piotroski F-Score
3
Weak vs own history
QoQ +50.0%
YoY −40.0%
now 32 low5 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Cipla Limited returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
  15 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  15 members-only factors: Beneish M-Score, Days Sales in Receivables Index, Gross Margin Index, Asset Quality Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Cipla Limited, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Cipla Limited fundamentals: income statement, balance sheet & cash flow

Cipla Limited reported revenue of 281.63bn INR and net income of 38.79bn INR in FY2026, the year ended 31 March 2026 — revenue up 3.3% and net income down 26.4% on the prior year. Free cash flow was 25.27bn INR. These figures are as reported in the filings, not restated: 23 fiscal years and 58 quarters of history, back to March 2004.

Revenue (FY2026)
281.63bn INR
+3.3%
Net income
38.79bn INR
-26.4%
Gross margin
42.74%
Free cash flow
25.27bn INR
-34.3%
Net debt
-4.04bn INR
Cipla Limited income statement, annual, as reported · INR billions unless stated
INR billionsFY2026FY2025FY2024FY2023FY2022
Period end31 Mar 202631 Mar 202531 Mar 202431 Mar 202331 Mar 2022
Revenue281.63272.67255.37225.59217.08
Cost of revenue161.2691.7590.4484.5586.90
Gross profit120.36180.92164.93141.04130.18
Research & development5.2114.8515.2312.932.66
Selling, general & admin.68.01————
Operating income47.14105.0194.8077.9680.85
EBITDA64.8171.2562.8950.2745.53
Interest expense0.540.620.791.100.91
Pre-tax income52.1667.9957.0040.3634.80
Income tax13.5415.3015.4712.039.34
Net income38.7952.7341.2228.0225.17

Download Cipla Limited fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.CIPLA.NSE&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 23 fiscal years and 58 quarters, the filing vintages behind each number and API access.
Create free account

Figures in INR, statements as filed. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic.

Research on Cipla Limited

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Cipla Limited Trading Strategies

28 backtested tactical asset allocation strategies hold EEM (emerging markets), the closest tradable exposure to Cipla Limited; 2 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

See all 28 strategies holding EEM →

Statistical Distribution of Returns

Plus

How Cipla Limited’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Cipla Limited behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Cipla Limited (India)

Cipla Limited is a listed security in India. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

Frequently asked questions

What is Cipla Limited?
Cipla Limited is a listed security in India. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Cipla Limited price?
The latest close is 1,387 (5 Nov 2026), +0.01% on the day. The price at the top of the page refreshes during the trading day.
Is Cipla Limited in an uptrend?
As of 5 Nov 2026, short-term momentum is positive (3 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is neutral (4 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Cipla Limited?
20-day realised volatility is 15.0% a year (5 Nov 2026), which implies a typical one-standard-deviation move of about 4.3% over a month and 2.1% over a week.
What factors affect Cipla Limited?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Cipla Limited, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Cipla Limited?
28 backtested tactical asset allocation strategies trade Cipla Limited through EEM; 2 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Cipla Limited returns analysed?
The Statistical Distribution of Returns section shows the distribution of Cipla Limited daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Cipla Limited historical data?
In the Free historical data section of this page: the last 10 years of Cipla Limited daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Cipla Limited historical data (last 10 years)

Browse or instantly download the last 10 years of Cipla Limited daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.CIPLA.NSE&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-201415
2026-11-191418.5
2026-11-181417
2026-11-171388
2026-11-161394.5
2026-11-131391.8
2026-11-121408.3
2026-11-111419.9
2026-11-091403.8
2026-11-081405.8
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney disorders, alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.